Catalyst Wire Dossier Catalyst Wire Dossier

Avzivi

bevacizumab · FGK Representative Service GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avzivi, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: EMA Authorised: Avzivi (bevacizumab) — FGK Representative Service GmbH

See pricing